Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in Oncology Retrieve available abstracts of 46 articles: HTML format

Single Articles

June 2021
1. BEILMANN-LEHTONEN I, Hagstrom J, Mustonen H, Koskensalo S, et al
   High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients.
   Oncology. 2021 Jun 17:1-12. doi: 10.1159/000516543.
   PubMed     Abstract available
   
   
   April 2021
2. TAMPAKIS A, Tampaki EC, Nonni A, Kontos M, et al
   MAP17 Expression in Colorectal Cancer Is a Prognostic Factor for Disease Recurrence and Dismal Prognosis Already in Early Stage Disease.
   Oncology. 2021 Apr 14:1-11. doi: 10.1159/000515596.
   PubMed     Abstract available
   
   
   February 2021
3. KAMEI Y, Takayama T, Suzuki T, Furihata K, et al
   Prediction of Recurrence in Patients with Stage III Colon Cancer Using Conventional Clinicopathological Factors and Peripheral Blood Test Data: A New Analysis with Artificial Intelligence.
   Oncology. 2021 Feb 24:1-9. doi: 10.1159/000513414.
   PubMed     Abstract available
   
   
   October 2020
4. DE RENZI G, Gaballo G, Gazzaniga P, Nicolazzo C, et al
   Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights.
   Oncology. 2020 Oct 30:1-9. doi: 10.1159/000510944.
   PubMed     Abstract available
   
   
   
5. PELTONEN R, Hagstrom J, Tervahartiala T, Sorsa T, et al
   High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
   Oncology. 2020 Oct 7:1-17. doi: 10.1159/000510609.
   PubMed     Abstract available
   
   
   June 2020
6. TOUMAZI D, Constantinou C
   A Fragile Balance: The Important Role of the Intestinal Microbiota in the Prevention and Management of Colorectal Cancer.
   Oncology. 2020 Jun 30:1-10. doi: 10.1159/000507959.
   PubMed     Abstract available
   
   
   
7. CHAN LF, Sadahiro S, Suzuki T, Okada K, et al
   Tissue-Infiltrating Lymphocytes as a Predictive Factor for Recurrence in Patients with Curatively Resected Colon Cancer: A Propensity Score Matching Analysis.
   Oncology. 2020 Jun 11:1-9. doi: 10.1159/000506706.
   PubMed     Abstract available
   
   
   May 2020
8. SADAHIRO S, Suzuki T, Okada K, Saito G, et al
   Oral S-1 with 24-h Infusion of Irinotecan plus Bevacizumab versus FOLFIRI plus Bevacizumab as First-Line Chemotherapy for Metastatic Colorectal Cancer: An Open-Label Randomized Phase II Trial.
   Oncology. 2020 May 29:1-6. doi: 10.1159/000507293.
   PubMed     Abstract available
   
   
   
9. DIMBERG J, Andersson RE, Haglund S
   Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.
   Oncology. 2020 May 14:1-8. doi: 10.1159/000507118.
   PubMed     Abstract available
   
   
   April 2020
10. SHINTO E, Oki E, Shimokawa M, Yamaguchi S, et al
    A Validation Study for Recurrence Risk Stratification of Stage II Colon Cancer Using the 55-Gene Classifier.
    Oncology. 2020 Apr 1:1-8. doi: 10.1159/000506369.
    PubMed     Abstract available
    
    
    February 2020
11. SATO Y, Inaba Y, Aramaki T, Sone M, et al
    Hepatic Arterial Infusion Chemotherapy of 5-Fluorouracil for Patients with Unresectable Liver Metastases from Colorectal Cancer Refractory to Standard Systemic Chemotherapy: A Multicenter Retrospective Study.
    Oncology. 2020 Feb 24:1-6. doi: 10.1159/000505520.
    PubMed     Abstract available
    
    
    January 2020
12. MATSUDA K, Tamura K, Iwamoto H, Mizumoto Y, et al
    Tumor Sidedness Is Associated with Survival in Patients with Synchronous Colorectal Peritoneal Carcinomatosis.
    Oncology. 2020;98:230-236.
    PubMed     Abstract available
    
    
    
13. HOLM M, Joenvaara S, Saraswat M, Tohmola T, et al
    Preoperative Radiotherapy Leads to Significant Differences in the Plasma Protein Profile of Rectal Cancer Patients.
    Oncology. 2020;98:493-500.
    PubMed     Abstract available
    
    
    
14. LIN CY, Hsieh PL, Chou CL, Yang CC, et al
    High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
    Oncology. 2020;98:549-557.
    PubMed     Abstract available
    
    
    
15. OKI E, Kawahira M, Kusumoto T, Yuki S, et al
    Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib Treatment (KSCC1603).
    Oncology. 2020;98:719-726.
    PubMed     Abstract available
    
    
    
16. MIYAKITA H, Sadahiro S, Suzuki T, Chan LF, et al
    Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.
    Oncology. 2020;98:869-875.
    PubMed     Abstract available
    
    
    November 2019
17. TIAN Y, Sun F, Zhong Y, Huang W, et al
    Expression and Clinical Significance of POLR1D in Colorectal Cancer.
    Oncology. 2019 Nov 13:1-8. doi: 10.1159/000504174.
    PubMed     Abstract available
    
    
    August 2019
18. OGIMI T, Sadahiro S, Kamei Y, Chan LF, et al
    Distribution of Neuroendocrine Marker-Positive Cells in Colorectal Cancer Tissue and Normal Mucosal Tissue: Consideration of Histogenesis of Neuroendocrine Cancer.
    Oncology. 2019 Aug 7:1-7. doi: 10.1159/000501521.
    PubMed     Abstract available
    
    
    June 2019
19. CHOI HH, Cho YS, Choi JH, Kim HK, et al
    Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
    Oncology. 2019 Jun 19:1-7. doi: 10.1159/000500639.
    PubMed     Abstract available
    
    
    April 2019
20. LARSEN FO, Jensen BV, Norgaard HH, Hermann HK, et al
    Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naive Patients with Liver Metastases from Colorectal Cancer.
    Oncology. 2019 Apr 18. pii: 000499314. doi: 10.1159/000499314.
    PubMed     Abstract available
    
    
    March 2019
21. TAMPAKIS A, Tampaki EC, Nonni A, Droeser R, et al
    Nectin-1 Expression in Colorectal Cancer: Is There a Group of Patients with High Risk for Early Disease Recurrence?
    Oncology. 2019 Mar 27:1-8. doi: 10.1159/000499569.
    PubMed     Abstract available
    
    
    February 2019
22. KOBAYASHI K, Kawakami K, Yokokawa T, Aoyama T, et al
    Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer.
    Oncology. 2019 Feb 14:1-7. doi: 10.1159/000495989.
    PubMed     Abstract available
    
    
    January 2019
23. SHIRATORI H, Kawai K, Hata K, Tanaka T, et al
    Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.
    Oncology. 2019;96:33-43.
    PubMed     Abstract available
    
    
    
24. YAMAMOTO A, Toiyama Y, Okugawa Y, Saigusa S, et al
    Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
    Oncology. 2019;96:70-78.
    PubMed     Abstract available
    
    
    
25. KUDO T, Takemasa I, Hata T, Sakai D, et al
    A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer.
    Oncology. 2019;97:211-216.
    PubMed     Abstract available
    
    
    December 2018
26. CHEN KH, Lin LI, Tseng LH, Lin YL, et al
    CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer.
    Oncology. 2018 Dec 12:1-8. doi: 10.1159/000493387.
    PubMed     Abstract available
    
    
    October 2018
27. HAYASHI K, Mitani S, Taniguchi H, Yasui H, et al
    Panitumumab Provides Better Survival Outcomes Compared to Cetuximab for Metastatic Colorectal Cancer Patients Treated with Prior Bevacizumab within 6 Months.
    Oncology. 2018 Oct 25:1-8. doi: 10.1159/000493321.
    PubMed     Abstract available
    
    
    August 2018
28. WILLIS D, Samalin E, Satge D
    Colorectal Cancer in People with Intellectual Disabilities.
    Oncology. 2018 Aug 31:1-14. doi: 10.1159/000492077.
    PubMed     Abstract available
    
    
    
29. OKADA K, Sadahiro S, Chan LF, Ogimi T, et al
    The Number of Natural Killer Cells in the Largest Diameter Lymph Nodes Is Associated with the Number of Retrieved Lymph Nodes and Lymph Node Size, and Is an Independent Prognostic Factor in Patients with Stage II Colon Cancer.
    Oncology. 2018 Aug 23:1-9. doi: 10.1159/000491019.
    PubMed     Abstract available
    
    
    
30. SANTASUSAGNA S, Moreno I, Navarro A, Martinez Rodenas F, et al
    Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients.
    Oncology. 2018 Aug 23:1-10. doi: 10.1159/000490726.
    PubMed     Abstract available
    
    
    
31. ITO N, Kawahira H, Nakashima H, Uesato M, et al
    Endoscopic Diagnostic Support System for cT1b Colorectal Cancer Using Deep Learning.
    Oncology. 2018 Aug 21:1-7. doi: 10.1159/000491636.
    PubMed     Abstract available
    
    
    July 2018
32. SEKINE K, Hamaguchi T, Shoji H, Takashima A, et al
    Retrospective Analyses of Systemic Chemotherapy and Cytoreductive Surgery for Patients with Ovarian Metastases from Colorectal Cancer: A Single-Center Experience.
    Oncology. 2018 Jul 20:1-9. doi: 10.1159/000489665.
    PubMed     Abstract available
    
    
    March 2018
33. TANIOKA H, Miyamoto Y, Tsuji A, Asayama M, et al
    Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).
    Oncology. 2018 Mar 7. pii: 000486624. doi: 10.1159/000486624.
    PubMed     Abstract available
    
    
    January 2018
34. PETRELLI F, Ardito R, Ghidini A, Zaniboni A, et al
    Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.
    Oncology. 2018 Jan 23. pii: 000486338. doi: 10.1159/000486338.
    PubMed     Abstract available
    
    
    
35. SAITO G, Sadahiro S, Ogimi T, Miyakita H, et al
    Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer.
    Oncology. 2018;94:167-175.
    PubMed     Abstract available
    
    
    
36. DE FELICE F, Martinetti MT, Orelli S, Bulzonetti N, et al
    Definitive Chemoradiotherapy for Anal Carcinoma: Long-Term Results Based on Consistent Time-to-Event Endpoints.
    Oncology. 2018;94:25-30.
    PubMed     Abstract available
    
    
    
37. HASS HG, Vogel U, Scheurlen M, Jobst J, et al
    Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the Liver.
    Oncology. 2018;95:211-219.
    PubMed     Abstract available
    
    
    
38. SUZUKI T, Sadahiro S, Tanaka A, Okada K, et al
    Outcomes of Local Excision plus Chemoradiotherapy in Patients with T1 Rectal Cancer.
    Oncology. 2018;95:246-250.
    PubMed     Abstract available
    
    
    
39. TOIYAMA Y, Oki S, Okugawa Y, Ide S, et al
    Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.
    Oncology. 2018;95:270-280.
    PubMed     Abstract available
    
    
    January 2017
40. DELHORME JB, Severac F, Waissi W, Romain B, et al
    Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal Margin.
    Oncology. 2017;93:183-190.
    PubMed     Abstract available
    
    
    
41. YAMADA M, Sakurai T, Komeda Y, Nagai T, et al
    Clinical Significance of Bmi1 Expression in Inflammatory Bowel Disease.
    Oncology. 2017;93 Suppl 1:20-26.
    PubMed     Abstract available
    
    
    
42. OGAWA S, Ishii T, Minaga K, Nakatani Y, et al
    The Feasibility of 18-mm-Diameter Colonic Stents for Obstructive Colorectal Cancers.
    Oncology. 2017;93 Suppl 1:43-48.
    PubMed     Abstract available
    
    
    
43. SAKURAI T, Adachi T, Kono M, Arizumi T, et al
    Prophylactic Suturing Closure Is Recommended after Endoscopic Treatment of Colorectal Tumors in Patients with Antiplatelet/Anticoagulant Therapy.
    Oncology. 2017;93 Suppl 1:27-29.
    PubMed     Abstract available
    
    
    
44. KOMEDA Y, Kashida H, Sakurai T, Asakuma Y, et al
    Magnifying Narrow Band Imaging (NBI) for the Diagnosis of Localized Colorectal Lesions Using the Japan NBI Expert Team (JNET) Classification.
    Oncology. 2017;93 Suppl 1:49-54.
    PubMed     Abstract available
    
    
    
45. OKAMOTO K, Watanabe T, Komeda Y, Kono T, et al
    Risk Factors for Postoperative Bleeding in Endoscopic Submucosal Dissection of Colorectal Tumors.
    Oncology. 2017;93 Suppl 1:35-42.
    PubMed     Abstract available
    
    
    
46. SUZUKI T, Sadahiro S, Tanaka A, Okada K, et al
    A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy.
    Oncology. 2017;93:287-294.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: